{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T04:51:42Z","timestamp":1682571102845},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00120-019-0945-y","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T18:10:50Z","timestamp":1557339050000},"page":"680-685","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Akuter Harnverhalt bei M\u00e4nnern: Die Wirksamkeit von Alpha-Blockern beim Katheterauslassversuch nach Harnverhalt"],"prefix":"10.1007","volume":"58","author":[{"given":"S.","family":"M\u00fchlst\u00e4dt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Oelke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"issue":"4","key":"945_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4103\/0970-1591.57917","volume":"25","author":"MS Agrawal","year":"2009","unstructured":"Agrawal MS, Yadav A, Yadav H, Singh AK, Lavania P, Jaiman R (2009) A prospective randomized study comparing alfuzosin and tamsulosin in the management of patients suffering from acute urinary retention caused by benign prostatic hyperplasia. Indian J Urol 25(4):474\u2013478","journal-title":"Indian J Urol"},{"issue":"7","key":"945_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ncpuro0836","volume":"4","author":"KE Andersson","year":"2007","unstructured":"Andersson KE, Gratzke C (2007) Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 4(7):368\u2013378","journal-title":"Nat Clin Pract Urol"},{"key":"945_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1464-410X.2005.05685.x","volume":"96","author":"L Annemans","year":"2005","unstructured":"Annemans L, Cleemput I, Lamotte M, McNeill A, Hargreave T (2005) The economic impact of using alfuzosin 10\u202fmg once daily in the management of acute urinary retention in the UK: a\u00a06-month analysis. BJU Int 96:566\u2013571","journal-title":"BJU Int"},{"issue":"7","key":"945_CR4","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/nau.23194","volume":"36","author":"A Bansal","year":"2017","unstructured":"Bansal A, Arora A (2017) Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis. Neurourol Urodyn 36(7):1757\u20131762","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"945_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/pds.4361","volume":"27","author":"Y Duan","year":"2018","unstructured":"Duan Y, Grady JJ, Albertsen PC, Wu HZ (2018) Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidemiol Drug Saf 27(3):340\u2013348","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"945_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/bmj.318.7188.921","volume":"318","author":"M Emberton","year":"1999","unstructured":"Emberton M, Anson K (1999) Acute urinary retention in men: an age old problem. BMJ 318:921\u2013925","journal-title":"BMJ"},{"key":"945_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006744.pub3","author":"E Fisher","year":"2014","unstructured":"Fisher E, Subramonian K, Omar MI (2014) The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006744.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"945_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0022-5347(17)64980-2","volume":"87","author":"HL Holtgrewe","year":"1962","unstructured":"Holtgrewe HL, Valk WJ (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy. J\u00a0Urol 87:450\u2013459","journal-title":"J Urol"},{"issue":"7","key":"945_CR9","first-page":"510","volume":"9","author":"LX Hua","year":"2003","unstructured":"Hua LX, Wu HF, Sui YG, Chen SG, Xu ZQ, Zhang W et\u00a0al (2003) Tamsulosin in the treatment of benign prostatic hyperplasia patients with acute urinary retention. Zhonghua Nan Ke Xue 9(7):510\u2013511","journal-title":"Zhonghua Nan. Ke Xue"},{"issue":"3","key":"945_CR10","first-page":"1673","volume":"11","author":"O Kara","year":"2014","unstructured":"Kara O, Yazici M (2014) Is the double dose alpha-blocker treatment superior than the single dose in the management of patients suffering from acute urinary retention caused by benign prostatic hyperplasia? Urol\u00a0J 11(3):1673\u20131677","journal-title":"Urol J"},{"issue":"1","key":"945_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.urology.2013.02.020","volume":"82","author":"S Kumar","year":"2013","unstructured":"Kumar S, Tiwari PD, Ganesamoni R, Singh SK (2013) Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention. Urology 82(1):171\u2013175","journal-title":"Urology"},{"issue":"3","key":"945_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5213\/inj.2011.15.3.158","volume":"15","author":"KS Lee","year":"2011","unstructured":"Lee KS, Lim KH, Kim SJ, Choi HJ, Noh DH, Lee HW, Cho MC (2011) Predictors of successful trial without catheter for postoperative urinary retention following non-urological surgery. Int Neurourol\u00a0J 15(3):158\u2013165","journal-title":"Int Neurourol J"},{"issue":"1","key":"945_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12877-018-0709-3","volume":"18","author":"YH Lin","year":"2018","unstructured":"Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Chen CL, Tsui KH (2018) Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. Bmc Geriatr 18(1):15","journal-title":"Bmc Geriatr"},{"issue":"3","key":"945_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1464-410X.2005.05299.x","volume":"95","author":"MG Lucas","year":"2005","unstructured":"Lucas MG, Stephenson TP, Nargund V (2005) Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int 95(3):354\u2013357","journal-title":"BJU Int"},{"issue":"4","key":"945_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11255-013-0515-y","volume":"46","author":"M Maldonado-\u00c1vila","year":"2014","unstructured":"Maldonado-\u00c1vila M, Manzanilla-Garc\u00eda HA, Sierra-Ram\u00edrez JA, Carrillo-Ruiz JD, Gonz\u00e1lez-Valle JC, Rosas-Nava E, Guzman-Esquivel J, Labra-Salgado IR (2014) A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth. Int Urol Nephrol 46(4):687\u2013690","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"945_CR16","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1464-410x.1999.00277.x","volume":"84","author":"SA McNeill","year":"1999","unstructured":"McNeill SA, Daruwala PD, Mitchell ID, Shearer MG, Hargreave TB (1999) Sustained-release alfuzosin and trial without catheter after acute urinary retention: A prospective, placebo-controlled. [comment. BJU Int 84(6):622\u2013627","journal-title":"BJU Int"},{"issue":"6 Pt 1","key":"945_CR17","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1097\/01.ju.0000127743.80759.7a","volume":"171","author":"SA McNeill","year":"2004","unstructured":"McNeill SA, Hargreave TB, Members of the Alfaur Study Group 2004 (2004) Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J\u00a0Urol 171(6 Pt 1):2316\u20132320","journal-title":"J Urol"},{"issue":"1","key":"945_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.urology.2004.07.042","volume":"65","author":"SA McNeill","year":"2005","unstructured":"McNeill SA, Hargreave TB, Roehrborn CG, Alfaur Study Group 2005 (2005) Alfuzosin 10\u202fmg once daily in the management of acute urinary retention: results of a\u00a0doubleblind placebo-controlled study. Urology 65(1):83\u201389 (discussion 89\u201390)","journal-title":"Urology"},{"key":"945_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0022-5347(17)40731-2","volume":"141","author":"WK Mebust","year":"1989","unstructured":"Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J\u00a0Urol 141:243\u2013247","journal-title":"J Urol"},{"key":"945_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0022-5347(17)59818-3","volume":"112","author":"J Melchior","year":"1974","unstructured":"Melchior J, Valk WJ, Foret JD, Mebust WK (1974) Transurethral prostatectomy in the azotemic patient. J\u00a0Urol 112:643\u2013646","journal-title":"J Urol"},{"issue":"Suppl 2","key":"945_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.bjp.0706619","volume":"147","author":"MC Michel","year":"2006","unstructured":"Michel MC, Vrydag W (2006) Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147(Suppl 2):88\u2013119","journal-title":"Br J Pharmacol"},{"key":"945_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1464-410X.1984.tb05825.x","volume":"56","author":"K Murray","year":"1984","unstructured":"Murray K, Massey A, Feneley RC (1984) Acute urinary retention a\u00a0urodynamic assessment. Br J Urol 56:468\u2013473","journal-title":"Br J Urol"},{"key":"945_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004201.pub2","author":"BS Ni\u00ebl-Weise","year":"2005","unstructured":"Ni\u00ebl-Weise BS, van den Broek PJ (2005) Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004201.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"945_CR24","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1517\/14740338.2014.936376","volume":"13","author":"M Oelke","year":"2014","unstructured":"Oelke M, Gericke A, Michel MC (2014) Cardiovascular and ocular safety of \u03b11-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms. Expert Opin Drug Saf 13(9):1187\u20131197","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"945_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00120-002-0236-9","volume":"41","author":"M Oelke","year":"2002","unstructured":"Oelke M, H\u00f6fner K, Berges RR, Jonas U (2002) Medikament\u00f6se Therapie des benignen Prostatasyndroms mit \u03b11-Rezeptorblockern \u2013 Grundlagen und klinische Ergebnisse. Urologe A 41(5):425\u2013441","journal-title":"Urologe A."},{"issue":"4","key":"945_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.urology.2015.06.025","volume":"86","author":"M Oelke","year":"2015","unstructured":"Oelke M, Speakman MJ, Desgrandchamps F, Mamoulakis C (2015) Acute urinary retention rates in the general male population and in adult men with lower urinary tract symptoms participating in pharmacotherapy trials: a\u00a0literature review. Urology 86(4):654\u2013665","journal-title":"Urology"},{"issue":"1","key":"945_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bju.12281","volume":"113","author":"MI Omar","year":"2014","unstructured":"Omar MI, Lam TB, Alexander CE, Graham J, Mamoulakis C, Imamura M et al (2014) Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP). BJU Int 113(1):24\u201335. \n                    https:\/\/doi.org\/10.1111\/bju.12281","journal-title":"BJU Int"},{"issue":"1","key":"945_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000137643","volume":"81","author":"L Prieto","year":"2008","unstructured":"Prieto L, Romero J, Lopez C, Ortiz M, Pacheco JJ (2008) Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia. Urol Int 81(1):66\u201371","journal-title":"Urol Int"},{"issue":"3","key":"945_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/01.ju.0000097026.43866.cc","volume":"171","author":"CG Roehrborn","year":"2004","unstructured":"Roehrborn CG, Schwinn DA (2004) Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J\u00a0Urol 171(3):1029\u20131035","journal-title":"J Urol"},{"key":"945_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1159\/000020189","volume":"37","author":"CG Roehrborn","year":"2000","unstructured":"Roehrborn CG, Bruskewitz R, Nickel GC, Glickman S, Cox C, Anderson R et\u00a0al (2000) Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS study group. Eur Urol 37:528\u2013536","journal-title":"Eur Urol"},{"key":"945_CR31","first-page":"1297","volume-title":"Campbell\u2019s Urology","author":"CG Roehrborn","year":"2002","unstructured":"Roehrborn CG, McConnell JD (2002) Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (Hrsg) Campbell\u2019s Urology, 8.\u00a0Aufl. Bd. 2. Saunders, Philadelphia, London, New York, S\u00a01297\u20131336","edition":"8"},{"issue":"Suppl 3","key":"945_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000049885","volume":"40","author":"CC Schulman","year":"2001","unstructured":"Schulman CC (2001) Long-term aspects of medical treatment of BPH. Eur Urol 40(Suppl 3):8\u201312","journal-title":"Eur Urol"},{"issue":"3","key":"945_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1442-2042.2007.01956.x","volume":"15","author":"DA Schwinn","year":"2008","unstructured":"Schwinn DA, Roehrborn CG (2008) Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol 15(3):193\u2013199","journal-title":"Int J Urol"},{"issue":"4","key":"945_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0302-2838(02)00319-6","volume":"42","author":"T Shah","year":"2002","unstructured":"Shah T, Palit V, Biyani S, Elmasry Y, Puri R, Flannigan GM (2002) Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention. Eur Urol 42(4):323\u2013332","journal-title":"Eur Urol"},{"issue":"2","key":"945_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/nau.23897","volume":"38","author":"C D\u2019Ancona","year":"2019","unstructured":"Standardisation Steering Committee ICS and the ICS Working Group on Terminology for Male Lower Urinary Tract & Pelvic Floor Symptoms and Dysfunction, D\u2019Ancona C, Haylen B, Oelke M et\u00a0al (2019) The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn 38(2):433\u2013477","journal-title":"Neurourol Urodyn"},{"key":"945_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000209","author":"BS Tae","year":"2019","unstructured":"Tae BS, Jeon BJ, Choi H, Cheon J, Park JY, Bae JH (2019) Alpha-blocker and risk of dementia in patients with benign prostate hyperplasia: a nationwide population-based study using the national health insurance service database. J\u00a0Urol. \n                    https:\/\/doi.org\/10.1097\/JU.0000000000000209","journal-title":"J Urol"},{"issue":"2","key":"945_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1464-410X.1989.tb05160.x","volume":"63","author":"M Taube","year":"1989","unstructured":"Taube M, Gajraj H (1989) Trial without catheter following acute retention of urine. Br J Urol 63(2):180\u2013182","journal-title":"Br J Urol"},{"issue":"Suppl 1","key":"945_CR38","first-page":"35","volume":"13","author":"MJB Tibung","year":"2006","unstructured":"Tibung MJB, Tiong HY, Macalalag M, Liew L, Li MK (2006) Alfuzosin XL prior to trial off catheter after acute urinary retention: early results from a\u00a0randomized, double-blinded, placebo-controlled trial. Int J Urol 13(Suppl 1):35","journal-title":"Int J Urol"},{"issue":"1","key":"945_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000224867","volume":"83","author":"HY Tiong","year":"2009","unstructured":"Tiong HY, Tibung MJ, Macalalag M, Li MK, Consigliere D (2009) Alfuzosin 10\u202fmg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. Urol Int 83(1):44\u201348","journal-title":"Urol Int"},{"issue":"4","key":"945_CR40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.eururo.2004.11.011","volume":"47","author":"KM Verhamme","year":"2005","unstructured":"Verhamme KM, Dieleman JP, van Wijk MA, Bosch JL, Stricker BH, Sturkenboom MC (2005) Low incidence of acute urinary retention in the general male population: the triumph project. Eur Urol 47(4):494\u2013498","journal-title":"Eur Urol"},{"key":"945_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-3-642-16499-6_14","volume":"202","author":"S Yamada","year":"2011","unstructured":"Yamada S, Ito Y (2011) Alpha(1)-adrenoceptors in the urinary tract. Handb Exp Pharmacol 202:283\u2013306","journal-title":"Handb Exp Pharmacol"},{"key":"945_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006744.pub2","author":"HJ Zeif","year":"2009","unstructured":"Zeif HJ, Subramonian K (2009) Alpha blockers prior to removal of a\u00a0catheter for acute urinary retention in adult men. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006744.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-0945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-019-0945-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-0945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T23:17:36Z","timestamp":1588807056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-019-0945-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s00120-019-0945-y","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"8 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0M\u00fchlst\u00e4dt und M.\u00a0Oelke geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}